Enterococcal bacteremia in children: Clinical Significance of vancomycin resistance

被引:0
|
作者
Jo, Kyo Jin [1 ]
Lee, Hyeon Seo [2 ]
Lee, Narae [1 ]
Byun, Shin Yun [1 ]
Chang, Chulhun [3 ]
Park, Su Eun [1 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Pediat, Yangsan, South Korea
[2] Pusan Natl Univ, Off Infect Control, Yangsan Hosp, Yangsan, South Korea
[3] Pusan Natl Univ, Sch Med, Dept Lab Med, Yangsan, South Korea
来源
PEDIATRICS AND NEONATOLOGY | 2025年 / 66卷 / 02期
关键词
Bacteremia; Children; Enterococcus; Vancomycin-resistant enterococci; BLOOD-STREAM INFECTIONS; RISK-FACTORS; EPIDEMIOLOGY;
D O I
10.1016/j.pedneo.2024.01.007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: We aimed to describe the clinical and microbiological characteristics of enterococcal bacteremia, as well as the effect of Enterococcus resistance against vancomycin on clinical outcomes in Korean children. Methods: We retrospectively reviewed the medical records of children diagnosed with enterococci isolated from blood cultures at Pusan National University Children's Hospital between December 2009 and November 2021. Results: In total, 64 patients were enrolled in the study. The median age was 0 years (range 0-15), and 43 (67.2%) patients were male. Enterococcus faecalis (50%) was the most commonly identified bacterial strain. Significant underlying diseases were present in 60 patients (93.8%), and the source of bacteremia was identified in 36 patients (56.3%). Among these, intravascular device was the most common identifiable source. Fifty-six (87.5%) patients had previously received broad-spectrum antibiotics and 54 (84.4%) patients were nosocomial in origin. Twenty-nine (45.3%) strains were resistant to ampicillin, and 16 (25%) strains were resistant to vancomycin. All patients with vancomycin-resistant enterococci (VRE) had underlying disease (P = 0.199), and focus of bacteremia was significantly more frequent in VRE patients (P = 0.014). Of all the patients, after appropriate antibiotic treatment, five (7.8%) patients had recurrent enterococcal bacteremia, and seven (10.9%) patients were diagnosed with bacteremia, defined as other pathogens from blood culture. The 30-day mortality rate was 7.8%. Conclusion: Enterococcal bacteremia in children is usually nosocomial and occurs in children with serious underlying diseases. Because the number of enrolled patients and mortality were small in our study, it is difficult to identify whether the factor that determines prognosis in patients with enterococcal bacteremia is VRE or an underlying disease. Further studies with a large number of patients in a specific group are needed.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 50 条
  • [1] Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance
    Bae, Kil-Seong
    Shin, Ju Ae
    Kim, Seong koo
    Han, Seung Beom
    Lee, Jae Wook
    Lee, Dong-Gun
    Chung, Nack-Gyun
    Cho, Bin
    Jeong, Dae Chul
    Kang, Jin Han
    INFECTION, 2019, 47 (03) : 417 - 424
  • [2] Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance
    Kil-Seong Bae
    Ju Ae Shin
    Seong koo Kim
    Seung Beom Han
    Jae Wook Lee
    Dong-Gun Lee
    Nack-Gyun Chung
    Bin Cho
    Dae Chul Jeong
    Jin Han Kang
    Infection, 2019, 47 : 417 - 424
  • [3] Outcome of enterococcal bacteremia:: A metaanalysis of the impact of vancomycin resistance
    Plantefève, G
    Dupont, H
    Mantz, J
    Desmonts, J
    INTENSIVE CARE MEDICINE, 2003, 29 : S132 - S132
  • [4] Vancomycin resistance and mortality associated with enterococcal bacteremia - Reply
    Linden, PK
    Pasculle, AW
    Manez, R
    Kramer, DJ
    Fung, JJ
    Pinna, AD
    Kusne, S
    CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) : 530 - 531
  • [5] Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia?
    Krcmery, V
    Bilíková, E
    Svetlansky, I
    Kovacicová, G
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) : 1110 - 1112
  • [6] Enterococcal bacteremia: Risk factors for vancomycin resistance and predictors of mortality
    Lautenbach, E
    Bilker, WB
    Brennan, PJ
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (05): : 318 - 323
  • [7] Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children
    Tamma, Pranita D.
    Hsu, Alice J.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2014, 27 (06) : 517 - 527
  • [8] Vancomycin resistant enterococcal (VRE) bacteremia in a children's hospital
    Ashkenazi, S
    Bar-Yohai, A
    Drucker, M
    Samra, Z
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1998, 19 (08): : 603 - 603
  • [9] Is vancomycin resistance in enterococci predictive of inferior outcome of enterococcal bacteremia? Reply
    Dylewski, J
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (07) : 1112 - 1112
  • [10] Vancomycin-resistant enterococcal bacteremia
    Boyce, JM
    CLINICAL INFECTIOUS DISEASES, 2002, 35 (11) : 1445 - 1446